Euphorbia is a very large and diverse genus of flowering plants, commonly called spurge, in the family Euphorbiaceae. "Euphorbia" is sometimes used in ordinary English to collectively refer to all members of Euphorbiaceae, not just to members of the genus.
The poinsettia is a commercially important plant species of the diverse spurge family (Euphorbiaceae). Indigenous to Mexico and Central America, the poinsettia was first described by Europeans in 1834. It is particularly well known for its red and green foliage and is widely used in Christmas floral displays. It derives its common English name from Joel Roberts Poinsett, the first United States Minister to Mexico, who is credited with introducing the plant to the US in the 1820s. Poinsettias are shrubs or small trees, with heights of 0.6–4 m (2.0–13.1 ft). Though often stated to be highly toxic, the poinsettia is not dangerous to pets or children. Exposure to the plant, even consumption, most often results in no effect, though it can cause nausea, vomiting, or diarrhea.
Opioids are substances that act on opioid receptors to produce morphine-like effects. Medically they are primarily used for pain relief, including anesthesia. Other medical uses include suppression of diarrhea, replacement therapy for opioid use disorder, reversing opioid overdose, and suppressing cough. Extremely potent opioids such as carfentanil are approved only for veterinary use. Opioids are also frequently used non-medically for their euphoric effects or to prevent withdrawal. Opioids can cause death and have been used for executions in the United States.
Hyperalgesia is an abnormally increased sensitivity to pain, which may be caused by damage to nociceptors or peripheral nerves and can cause hypersensitivity to stimulus. Prostaglandins E and F are largely responsible for sensitizing the nociceptors. Temporary increased sensitivity to pain also occurs as part of sickness behavior, the evolved response to infection.
Euphorbia amygdaloides, the wood spurge, is a species of flowering plant in the family Euphorbiaceae, native to woodland locations in Europe, Turkey and the Caucasus. It is a bushy evergreen perennial, growing to a height of 80 cm (31 in), with dark green slightly hairy leaves about 6 cm (2 in) long. The complex green-yellow inflorescence (cyathium), typical of Euphorbia, appears in late spring and early summer.
Euphorbia tithymaloides is a perennial succulent spurge. An erect shrub, the plant is also known by the scientific name Pedilanthus tithymaloides. However, the genus Pedilanthus has been submerged into the genus Euphorbia, and is more correctly known by its new name.
Euphorbia milii, the crown of thorns, Christ plant, or Christ thorn, is a species of flowering plant in the spurge family Euphorbiaceae, native to Madagascar. The species name commemorates Baron Milius, once Governor of Réunion, who introduced the species to France in 1821. It is imagined that the species was introduced to the Middle East in ancient times, and legend associates it with the crown of thorns worn by Christ. It is commonly used as an ornamental houseplant that can be grown in warmer climates. The common name is due to the thorns and deep red bracts referring to the crown thorn Jesus had to wear during his crucifixion and his blood.
Euphorbia resinifera, the resin spurge, is a species of spurge native to Morocco, where it occurs on the slopes of the Atlas Mountains. The dried latex of the plant was used in ancient medicine. It contains resiniferatoxin, a capsaicin analog tested as an analgesic since 1997.
Euphorbia lathyris, the caper spurge or paper spurge, is a species of spurge native to southern Europe, northwest Africa, and eastward through southwest Asia to western China.
Euphorbia maculata, known as spotted spurge or prostrate spurge, the latter name not to be confused with Euphorbia prostrata, is a fast-growing annual plant in the family Euphorbiaceae, native to North America. It is a common garden and lawn weed in the United States.
The nociceptin opioid peptide receptor (NOP), also known as the nociceptin/orphanin FQ (N/OFQ) receptor or kappa-type 3 opioid receptor, is a protein that in humans is encoded by the OPRL1 gene. The nociceptin receptor is a member of the opioid subfamily of G protein-coupled receptors whose natural ligand is the 17 amino acid neuropeptide known as nociceptin (N/OFQ). This receptor is involved in the regulation of numerous brain activities, particularly instinctive and emotional behaviors. Antagonists targeting NOP are under investigation for their role as treatments for depression and Parkinson's disease, whereas NOP agonists have been shown to act as powerful, non-addictive painkillers in non-human primates.
Hypoalgesia or hypalgesia denotes a decreased sensitivity to painful stimuli.
Methylnaltrexone, used in form of methylnaltrexone bromide, is a medication that acts as a peripherally acting μ-opioid receptor antagonist that acts to reverse some of the side effects of opioid drugs such as constipation without significantly affecting pain relief or precipitating withdrawals. Because MNTX is a quaternary ammonium cation, it cannot cross the blood–brain barrier, and so has antagonist effects throughout the body, counteracting effects such as itching and constipation, but without affecting opioid effects in the brain such as pain relief. However, since a significant fraction of opioid analgesia can be mediated by opioid receptors on peripheral sensory neurons, particularly in inflammatory conditions such as arthritis, traumatic or surgical pain, MNTX may increase pain under such circumstances.
Euphorbia candelabrum is a succulent species of plant in the family Euphorbiaceae, one of several plants commonly known as candelabra tree. It is endemic to the Horn of Africa and eastern Africa along the East African Rift system. It is known in Ethiopia by its Amharic name, qwolqwal, or its Oromo name, adaamii. It is closely related to three other species of Euphorbia: Euphorbia ingens in the dry regions of southern Africa, Euphorbia conspicua from western Angola, and Euphorbia abyssinica, which is native to countries including Sudan, Eritrea, Djibouti, Ethiopia and Somalia.
Euphorbia corollata is an herbaceous perennial plant in the family Euphorbiaceae that is native to North America. A common name for the species is flowering spurge. It has a milky sap that can cause skin and eye irritation in some people. It grows up to 1 m (3 ft) tall, with smooth stems and light green leaves arranged alternately or in whorls. Leaves are about 10 mm wide and 75 mm (3 in) long. Each stem terminates in a panicle 20 to 25 mm across. Flowers are about 6 mm across and consist of one pistillate and several staminate flowers surrounded by five white bracts - not petals but formed from the involucre at the base of the flowers. Flowering spurge blooms from June to September.
Euphorbiaceae, the spurge family, is a large family of flowering plants. In English, they are also commonly called euphorbias, which is also the name of a genus in the family. Most spurges, such as Euphorbia paralias, are herbs, but some, especially in the tropics, are shrubs or trees, such as Hevea brasiliensis. Some, such as Euphorbia canariensis, are succulent and resemble cacti because of convergent evolution. This family has a cosmopolitan global distribution. The greatest diversity of species is in the tropics, however, the Euphorbiaceae also have many species in nontropical areas of all continents except Antarctica.
Euphorbia ingens is a species of flowering plant in the family Euphorbiaceae. It is native to dry areas of southern Africa. It is popularly known as the candelabra tree or naboom. Its milky latex can be extremely poisonous and is a dangerous irritant.
Electroanalgesia is a form of analgesia, or pain relief, that uses electricity to ease pain. Electrical devices can be internal or external, at the site of pain (local) or delocalized throughout the whole body. It works by interfering with the electric currents of pain signals, inhibiting them from reaching the brain and inducing a response; different from traditional analgesics, such as opiates which mimic natural endorphins and NSAIDs that help relieve inflammation and stop pain at the source. Electroanalgesia has a lower addictive potential and poses less health threats to the general public, but can cause serious health problems, even death, in people with other electrical devices such as pacemakers or internal hearing aids, or with heart problems.
(+)-Naloxone (dextro-naloxone) is a drug which is the opposite enantiomer of the opioid antagonist drug (−)-naloxone. Unlike (-)-naloxone, (+)-naloxone has no significant affinity for opioid receptors, but instead has been discovered to act as a selective antagonist of Toll-like receptor 4. This receptor is involved in immune system responses, and activation of TLR4 induces glial activation and release of inflammatory mediators such as TNF-α and Interleukin-1.
Naloxegol is a peripherally acting μ-opioid receptor antagonist developed by AstraZeneca, licensed from Nektar Therapeutics, for the treatment of opioid-induced constipation. It was approved in 2014 in adult patients with chronic, non-cancer pain. Doses of 25 mg were found safe and well tolerated for 52 weeks. When given concomitantly with opioid analgesics, naloxegol reduced constipation-related side effects, while maintaining comparable levels of analgesia.
